NEO
- NeoGenomics, Inc.
()
Overview
Company Summary
NeoGenomics, Inc. is a company that primarily operates in the field of cancer diagnostics and genetics. It provides genetic testing and comprehensive laboratory services to physicians, hospitals, and pharmaceutical companies. NeoGenomics focuses on providing accurate and timely testing services to aid in the diagnosis, monitoring, and treatment of various types of cancer.
The company's services encompass a wide range of testing options, including molecular and genetic testing, flow cytometry, cytogenetics, and histology. These tests help healthcare professionals determine the type, subtype, and progression of cancer, enabling them to make more informed treatment decisions for their patients.
NeoGenomics operates a network of highly advanced, high-complexity laboratories, strategically located throughout the United States, to ensure efficient and reliable testing capability. They continuously invest in cutting-edge technologies and methodologies to stay at the forefront of cancer diagnostics.
In addition to clinical services, NeoGenomics also collaborates with pharmaceutical companies in conducting clinical trials, where they provide essential laboratory services for drug development and testing. This helps pharmaceutical companies in evaluating the effectiveness of their therapies and contributing to advancing cancer research.
Overall, NeoGenomics plays a crucial role in the fight against cancer by providing accurate and comprehensive diagnostic testing services, aiding in the development of targeted therapies, and contributing to the advancement of cancer treatment options.